Invo Fertility Inc (IVF) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access IVF Annual Cash Flow →
From Invo Fertility Inc through Jun 30 2025, changes in Jun 30 2026's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-9.25
Depreciation & amortization0.29
Amortization of Other Assets0.22
Increase (Decrease) in Deferred Revenue0.07
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.04
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.28
Income (Loss) from Equity Method Investments0.02
Financial Instruments and Foreign Currency Transaction3.62
Notes Issued-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Debt Conversion Original Debt Amount-
Amortization Of Discount On Notes Payable Options-
Noncash Stock Compensation Issued For Services-
Loss From Equity Method Investments-
Debt Conversion Expense-
Operating Lease Right Of Use Asset Amortization Expense Income-
Noncash Compensation For Services0.14
Increase Decrease In Accrued Compensation-
Operating Lease Right Of Use Asset Amortization Expense-
Reserve On Other Assets-
Equity Securities Fv Ni Gain Loss-
Gain Loss Related To Litigation Settlement0.01
Increase Decrease In Equity Securities Fv Ni-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.34
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.49
Increase (Decrease) in Interest Payable, Net0.03
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.10
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.72
Discontinued operations0.00
Net Cash flow from Operating Activities-3.02
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Patents-
Payments To Acquire Trademarks-
Investment In Joint Ventures-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-0.21
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.02
Interest in Subsidiaries and Affiliates0.00
Payments for (Proceeds from) Businesses and Interest in Affiliates0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.21
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.18
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.10
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock7.10
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-9.13
Proceeds From The Sale Of Common Stock Related Parties-
Proceeds From Convertible Notes Payable Related Parties-
Proceeds From Unit Purchase Option Exercise-
Proceeds From Sales Notes Payable-
Proceeds From Units Purchase Option Exercise-
Proceeds From Option Exercises-
Proceeds From Sale Of Notes Payable Related Parties-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.89
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.04
Total Cash Flow1.66
4 historic quarters locked

Sign in to unlock the full Invo Fertility Inc cash flow history.

About Invo Fertility Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-038528

Figures are derived from filed reports and may be restated. Historical data is subject to revision.